Skip to main content
Top

Rheumatology International

Issue 3/1998

Content (7 Articles)

ORIGINAL ARTICLE

IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis

T. Witte, K. Hartung, C. Sachse, T. Matthias, M. Fricke, H. Deicher, J. R. Kalden, H. J. Lakomek, H. H. Peter, R. E. Schmidt

ORIGINAL ARTICLE

Articular involvement in patients with relapsing polychondritis

I. Günaydin, T. Daikeler, S. Jacki, M. Mohren, L. Kanz, I. Kötter

ORIGINAL ARTICLE

Urinary neopterin excretion and dihydropteridine reductase activity in rheumatoid arthritis

Z. Z. Altindağ, G. Şahin, F. Ìnanici, Z. Hasçelik

ORIGINAL ARTICLE

Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study

M. Nagashima, S. Yoshino, H. Tanaka, N. Yoshida, N. Kashiwagi, A. R. Saniabadi

ORIGINAL ARTICLE

Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis

T. Jónsson, K. Steinsson, H. Jónsson, Á. J. Geirsson, J. Thorsteinsson, H. Valdimarsson

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine